ONDEXXYA
ONDEXXYA
Approved
DIN Number
02538539
Drug Class
Human
Market Date
May 27, 2024
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02538539
AIG Number0164721001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
V03AB38 ANDEXANET ALFA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
Health Canada Classification
ACTIVE INGREDIENTS (1)
ANDEXANET ALFAActive
Strength: 200 MG / VIAL
Monograph: ANDEXANET ALFA